Since the tumor uptake of an amino acid targeting LAT1 is associated with its blood concentration [11,14], maintaining the blood radioactivity level could be an effective strategy to increase the accumulation of 2-211At-AAMP in tumors. The gene discussed is SLC7A5; the disease is neoplasm.